ARROWHEAD PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $18.17 million for the 6-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-08
- ARROWHEAD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was $16.82M.
- ARROWHEAD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $1.36M.
- ARROWHEAD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$4.22M.
- ARROWHEAD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$12.93M, a 236.63% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$48.64M, a 461.73% decline from fiscal 2016.
- ARROWHEAD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $13.45M, a 4.77% decline from fiscal 2015.
- ARROWHEAD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $14.12M.
- ARROWHEAD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$36.48M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 98 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 101 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 104 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 107 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 110 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 113 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 116 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 119 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 122 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 125 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 128 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $16.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | $18.17M 10-Q · filed 2018-05-08 | $13.95M derived: sum of 3 quarters · filed 2018-05-08 | $1.03M derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||||
| 2017-12-31 | $1.36M 10-Q · filed 2018-02-09 | -$2.86M derived: sum of 2 quarters · filed 2018-02-09 | -$15.79M derived: sum of 3 quarters · filed 2018-02-09 | -$41.99M derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||||
| 2017-09-30 | -$4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | -$17.14M derived: sum of 2 quarters · filed 2017-12-12 | -$43.35M derived: sum of 3 quarters · filed 2018-05-08 | -$48.64M 10-K · filed 2017-12-12 | ||||||||||||
| 2017-06-30 | -$12.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | -$39.13M derived: sum of 2 quarters · filed 2018-05-08 | -$44.43M 10-Q · filed 2017-08-03 | -$46.14M derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||||
| 2017-03-31 | -$26.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | -$31.50M 10-Q · filed 2018-05-08 | -$33.21M derived: sum of 3 quarters · filed 2018-05-08 | -$23.75M derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||||
| 2016-12-31 | -$5.30M 10-Q · filed 2018-02-09 | -$7.01M derived: sum of 2 quarters · filed 2018-02-09 | $2.45M derived: sum of 3 quarters · filed 2018-02-09 | $5.56M derived: sum of 4 quarters · filed 2018-02-09 | ||||||||||||
| 2016-09-30 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | $7.75M derived: sum of 2 quarters · filed 2017-12-12 | $10.85M derived: sum of 3 quarters · filed 2017-12-12 | $13.45M 10-K · filed 2017-12-12 | ||||||||||||
| 2016-06-30 | $9.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $12.57M derived: sum of 2 quarters · filed 2017-08-03 | $15.16M 10-Q · filed 2017-08-03 | $21.01M derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2016-03-31 | $3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-03 | $5.70M 10-Q · filed 2017-05-03 | $11.54M derived: sum of 3 quarters · filed 2017-12-12 | $15.52M derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2015-12-31 | $2.59M 10-Q · filed 2017-02-06 | $8.44M derived: sum of 2 quarters · filed 2017-12-12 | $12.42M derived: sum of 3 quarters · filed 2017-12-12 | $21.21M derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2015-09-30 | $5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | $9.82M derived: sum of 2 quarters · filed 2017-12-12 | $18.62M derived: sum of 3 quarters · filed 2017-12-12 | $14.12M 10-K · filed 2017-12-12 | ||||||||||||
| 2015-06-30 | $3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $12.78M derived: sum of 2 quarters · filed 2016-08-09 | $8.28M 10-Q · filed 2016-08-09 | $12.82M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2015-03-31 | $8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $4.30M 10-Q · filed 2016-05-10 | $8.84M derived: sum of 3 quarters · filed 2016-12-14 | $9.78M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-12-31 | -$4.50M 10-Q · filed 2016-02-09 | $45.25K derived: sum of 2 quarters · filed 2016-12-14 | $981.62K derived: sum of 3 quarters · filed 2016-12-14 | -$25.84M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-09-30 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $5.48M derived: sum of 2 quarters · filed 2016-12-14 | -$21.34M derived: sum of 3 quarters · filed 2016-12-14 | -$36.48M 10-K · filed 2016-12-14 | ||||||||||||
| 2014-06-30 | $936.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | -$25.88M derived: sum of 2 quarters · filed 2015-08-04 | -$41.03M 10-Q · filed 2015-08-04 | -$47.55M derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||
| 2014-03-31 | -$26.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | -$41.96M 10-Q · filed 2015-05-11 | -$48.48M derived: sum of 3 quarters · filed 2015-12-14 | -$52.74M derived: sum of 4 quarters · filed 2015-12-14 | -$54.81M 10-Q · filed 2014-05-06 | |||||||||||
| 2013-12-31 | -$15.15M 10-Q · filed 2015-02-09 | -$21.67M derived: sum of 2 quarters · filed 2015-12-14 | -$25.92M derived: sum of 3 quarters · filed 2015-12-14 | -$24.78M derived: sum of 4 quarters · filed 2015-12-14 | -$28.00M 10-Q · filed 2014-02-04 | |||||||||||
| 2013-09-30 | -$6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | -$10.78M derived: sum of 2 quarters · filed 2015-12-14 | -$9.63M derived: sum of 3 quarters · filed 2015-12-14 | -$9.52M 10-K · filed 2015-12-14 | -$12.85M 10-K · filed 2013-12-18 | |||||||||||
| 2013-06-30 | -$4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | -$3.11M derived: sum of 2 quarters · filed 2014-08-12 | -$3.00M 10-Q · filed 2014-08-12 | -$2.82M derived: sum of 4 quarters · filed 2014-11-25 | -$6.33M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-06 | $1.26M 10-Q · filed 2014-05-06 | $1.44M derived: sum of 3 quarters · filed 2014-11-25 | $1.36M derived: sum of 4 quarters · filed 2014-11-25 | -$2.07M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | $111.98K 10-Q · filed 2014-02-04 | $290.34K derived: sum of 2 quarters · filed 2014-11-25 | $214.29K derived: sum of 3 quarters · filed 2014-11-25 | $13.00K derived: sum of 4 quarters · filed 2014-11-25 | -$3.22M 10-Q · filed 2013-02-13 | |||||||||||
| 2012-09-30 | $178.36K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $102.31K derived: sum of 2 quarters · filed 2014-11-25 | -$98.98K derived: sum of 3 quarters · filed 2014-11-25 | $440.64K 10-K · filed 2014-11-25 | -$3.33M 10-K · filed 2012-12-28 | |||||||||||
| 2012-06-30 | -$76.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07 | -$277.34K derived: sum of 2 quarters · filed 2013-08-07 | $262.28K 10-Q · filed 2013-08-07 | $666.66K derived: sum of 4 quarters · filed 2013-08-07 | -$3.51M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | -$201.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | $338.33K 10-Q · filed 2013-05-09 | $742.71K derived: sum of 3 quarters · filed 2013-05-09 | $1.28M derived: sum of 4 quarters · filed 2013-05-09 | -$3.43M 10-Q · filed 2012-05-08 | |||||||||||
| 2011-12-31 | $539.62K 10-Q · filed 2013-02-13 | $944.00K derived: sum of 2 quarters · filed 2013-02-13 | $1.48M derived: sum of 3 quarters · filed 2013-02-13 | -$3.23M 10-Q · filed 2012-02-09 | ||||||||||||
| 2011-09-30 | $404.38K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | $941.20K derived: sum of 2 quarters · filed 2012-12-28 | -$175.38K 10-K · filed 2012-12-28 | -$3.77M 10-Q · filed 2012-08-13 | ||||||||||||
| 2011-06-30 | $536.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-13 | -$579.76K 10-Q · filed 2012-08-13 | -$4.17M 10-Q · filed 2011-08-08 | |||||||||||||
| 2011-03-31 | -$1.12M 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |